Literature DB >> 20880500

Microglial activation and chronic neurodegeneration.

Melinda E Lull1, Michelle L Block.   

Abstract

Microglia, the resident innate immune cells in the brain, have long been implicated in the pathology of neurodegenerative diseases. Accumulating evidence points to activated microglia as a chronic source of multiple neurotoxic factors, including tumor necrosis factor-α, nitric oxide, interleukin-1β, and reactive oxygen species (ROS), driving progressive neuron damage. Microglia can become chronically activated by either a single stimulus (e.g., lipopolysaccharide or neuron damage) or multiple stimuli exposures to result in cumulative neuronal loss with time. Although the mechanisms driving these phenomena are just beginning to be understood, reactive microgliosis (the microglial response to neuron damage) and ROS have been implicated as key mechanisms of chronic and neurotoxic microglial activation, particularly in the case of Parkinson's disease. We review the mechanisms of neurotoxicity associated with chronic microglial activation and discuss the role of neuronal death and microglial ROS driving the chronic and toxic microglial phenotype.
Copyright © 2010 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20880500      PMCID: PMC2951017          DOI: 10.1016/j.nurt.2010.05.014

Source DB:  PubMed          Journal:  Neurotherapeutics        ISSN: 1878-7479            Impact factor:   7.620


  177 in total

1.  Microglial activation in early stages of amyloid beta protein deposition.

Authors:  A Sasaki; H Yamaguchi; A Ogawa; S Sugihara; Y Nakazato
Journal:  Acta Neuropathol       Date:  1997-10       Impact factor: 17.088

2.  MAC1 mediates LPS-induced production of superoxide by microglia: the role of pattern recognition receptors in dopaminergic neurotoxicity.

Authors:  Zhong Pei; Hao Pang; Li Qian; Sufen Yang; Tonggauang Wang; Wei Zhang; Xeufei Wu; Shannon Dallas; Belinda Wilson; Jeffrey M Reece; David S Miller; Jau-Shyong Hong; Michelle L Block
Journal:  Glia       Date:  2007-10       Impact factor: 7.452

3.  Activation of murine microglial cell lines by lipopolysaccharide and interferon-gamma causes NO-mediated decreases in mitochondrial and cellular function.

Authors:  D W Moss; T E Bates
Journal:  Eur J Neurosci       Date:  2001-02       Impact factor: 3.386

4.  Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Authors:  D Blum-Degen; T Müller; W Kuhn; M Gerlach; H Przuntek; P Riederer
Journal:  Neurosci Lett       Date:  1995-12-29       Impact factor: 3.046

5.  Hippocampal CA1 atrophy and synaptic loss during experimental autoimmune encephalomyelitis, EAE.

Authors:  Marina O Ziehn; Andrea A Avedisian; Seema Tiwari-Woodruff; Rhonda R Voskuhl
Journal:  Lab Invest       Date:  2010-02-15       Impact factor: 5.662

6.  In utero bacterial endotoxin exposure causes loss of tyrosine hydroxylase neurons in the postnatal rat midbrain.

Authors:  ZaoDung Ling; Dave A Gayle; Shang Yong Ma; Jack W Lipton; Chong Wai Tong; Jau-Shyong Hong; Paul M Carvey
Journal:  Mov Disord       Date:  2002-01       Impact factor: 10.338

Review 7.  COX-2 and neurodegeneration in Parkinson's disease.

Authors:  P Teismann; M Vila; D-K Choi; K Tieu; D C Wu; V Jackson-Lewis; S Przedborski
Journal:  Ann N Y Acad Sci       Date:  2003-06       Impact factor: 5.691

8.  Brain microglia/macrophages express neurotrophins that selectively regulate microglial proliferation and function.

Authors:  S Elkabes; E M DiCicco-Bloom; I B Black
Journal:  J Neurosci       Date:  1996-04-15       Impact factor: 6.167

9.  Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases.

Authors:  Avik Roy; Arundhati Jana; Kavitha Yatish; Matthew B Freidt; Yiu K Fung; Jeffrey A Martinson; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2008-06-06       Impact factor: 7.376

10.  The effects of aging, injury and disease on microglial function: a case for cellular senescence.

Authors:  Kelly R Miller; Wolfgang J Streit
Journal:  Neuron Glia Biol       Date:  2007-08
View more
  314 in total

Review 1.  Targeting NOX enzymes in the central nervous system: therapeutic opportunities.

Authors:  Silvia Sorce; Karl-Heinz Krause; Vincent Jaquet
Journal:  Cell Mol Life Sci       Date:  2012-05-30       Impact factor: 9.261

2.  In vivo imaging of activated microglia in a mouse model of focal cerebral ischemia by two-photon microscopy.

Authors:  Seoyeon Bok; Taejun Wang; Chan-Ju Lee; Seong-Uk Jeon; Young-Eun Kim; Jeongwoo Kim; Beom-Ju Hong; Calvin Jinse Yoon; Sungjee Kim; Seung-Hoon Lee; Hak Jae Kim; Il Han Kim; Ki Hean Kim; G-One Ahn
Journal:  Biomed Opt Express       Date:  2015-08-07       Impact factor: 3.732

Review 3.  Central nervous system myeloid cells as drug targets: current status and translational challenges.

Authors:  Knut Biber; Thomas Möller; Erik Boddeke; Marco Prinz
Journal:  Nat Rev Drug Discov       Date:  2015-12-04       Impact factor: 84.694

4.  Induction of matrix metalloproteinase-3 (MMP-3) expression in the microglia by lipopolysaccharide (LPS) via upregulation of glycoprotein nonmetastatic melanoma B (GPNMB) expression.

Authors:  Fangyuan Shi; Shuangyan Duan; Jihong Cui; Xingrong Yan; Hongmin Li; Yingjuan Wang; Fulin Chen; Lihua Zhang; Jun Liu; Xin Xie
Journal:  J Mol Neurosci       Date:  2014-03-30       Impact factor: 3.444

5.  Translocator protein 18 kDa negatively regulates inflammation in microglia.

Authors:  Keun-Ryung Bae; Hyun-Jung Shim; Deebika Balu; Sang Ryong Kim; Seong-Woon Yu
Journal:  J Neuroimmune Pharmacol       Date:  2014-04-01       Impact factor: 4.147

Review 6.  Inflammation in Alzheimer's disease: Lessons learned from microglia-depletion models.

Authors:  Elizabeth E Spangenberg; Kim N Green
Journal:  Brain Behav Immun       Date:  2016-07-06       Impact factor: 7.217

Review 7.  NADPH oxidase- and mitochondria-derived reactive oxygen species in proinflammatory microglial activation: a bipartisan affair?

Authors:  Evan A Bordt; Brian M Polster
Journal:  Free Radic Biol Med       Date:  2014-08-01       Impact factor: 7.376

8.  δ-Opioid receptor activation ameliorates lipopolysaccharide-induced inflammation and apoptosis by inhibiting the MAPK/caspase-3 pathway in BV2 microglial cells.

Authors:  Min Cheng; Yue Geng; Yeting Chen; Yongjie Zhang; Runjie Guo; Hong Xu; Jianfeng Liang; Jiajun Xie; Zean Zhang; Xuesong Tian
Journal:  Exp Brain Res       Date:  2020-11-18       Impact factor: 1.972

9.  Novel mGluR5 positive allosteric modulator improves functional recovery, attenuates neurodegeneration, and alters microglial polarization after experimental traumatic brain injury.

Authors:  David J Loane; Bogdan A Stoica; Flaubert Tchantchou; Alok Kumar; James P Barrett; Titilola Akintola; Fengtian Xue; P Jeffrey Conn; Alan I Faden
Journal:  Neurotherapeutics       Date:  2014-10       Impact factor: 7.620

Review 10.  Nrf2--a therapeutic target for the treatment of neurodegenerative diseases.

Authors:  Delinda A Johnson; Jeffrey A Johnson
Journal:  Free Radic Biol Med       Date:  2015-08-14       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.